edoc

Oral fingolimod (FTY720) in relapsing multiple sclerosis : impact on health-related quality of life in a phase II study

Montalban, X. and Comi, G. and O'Connor, P. and Gold, Sm and de Vera, A. and Eckert, B. and Kappos, L.. (2011) Oral fingolimod (FTY720) in relapsing multiple sclerosis : impact on health-related quality of life in a phase II study. Multiple Sclerosis Journal, 17 (11). pp. 1341-1350.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6004559

Downloads: Statistics Overview

Abstract

Health-related quality of life (HRQoL) worsens with multiple sclerosis (MS) relapses and disease progression. Common symptoms including depression and fatigue may contribute to poor HRQoL.
Faculties and Departments:03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos)
UniBasel Contributors:Kappos, Ludwig
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:SAGE
ISSN:1352-4585
e-ISSN:1477-0970
Note:Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
Last Modified:02 Nov 2017 13:31
Deposited On:06 Dec 2013 09:36

Repository Staff Only: item control page